XML 35 R10.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Fair Value Measurements | 12 Months Ended
--- | ---
Dec. 31, 2018
Fair Value Disclosures [Abstract] |
Fair Value Measurements | FAIR VALUE MEASUREMENTS Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:
Level 1 | Quoted market prices in active markets for identical assets or liabilities.
Level 2 | Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3 | Unobservable inputs reflecting our assumptions or external inputs from active markets.
Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges are included in Level 2 and we use inputs other than quoted prices that are observable for the asset or liability. The Level 2 derivative instruments are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense and the changes in the time value of money within other income (expense), net.
Assets Measured at Fair Value
| 2018 | 2017
Cash and cash equivalents | $ | 3,616 |  | $ | 2,542 |
Trading marketable securities | 118 |  | 121 |
Level 1 - Assets | $ | 3,734 |  | $ | 2,663 |
Available-for-sale marketable securities: |  |
Corporate and asset-backed debt securities | $ | 38 |  | $ | 125 |
Foreign government debt securities | — |  | 2 |
United States agency debt securities | 11 |  | 27 |
United States treasury debt securities | 23 |  | 70 |
Certificates of deposit | 11 |  | 27 |
Total available-for-sale marketable securities | $ | 83 |  | $ | 251 |
Foreign currency exchange forward contracts | 77 |  | 15 |
Interest rate swap asset | — |  | 49 |
Level 2 - Assets | $ | 160 |  | $ | 315 |
Total assets measured at fair value | $ | 3,894 |  | $ | 2,978 |
Liabilities Measured at Fair Value
| 2018 | 2017
Deferred compensation arrangements | $ | 118 |  | $ | 121 |
Level 1 - Liabilities | $ | 118 |  | $ | 121 |
Foreign currency exchange forward contracts | $ | 20 |  | $ | 37 |
Level 2 - Liabilities | $ | 20 |  | $ | 37 |
Contingent consideration: |  |
Beginning | $ | 32 |  | $ | 86 |
Additions | 77 |  | 3 |
Change in estimate | 15 |  | 2 |
Settlements | (7 | ) | (59 | )
Ending | $ | 117 |  | $ | 32 |
Level 3 - Liabilities | $ | 117 |  | $ | 32 |
Total liabilities measured at fair value | $ | 255 |  | $ | 190 |
Fair Value of Available for Sale Securities by Maturity
| 2018 | 2017
Due in one year or less | $ | 51 |  | $ | 107 |
Due after one year through three years | $ | 32 |  | $ | 144 |
On December 31, 2018 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest receivable was $1 and $1 in 2018 and 2017 related to our marketable security portfolio. Interest and marketable securities income was $119, $60, and $29 in 2018, 2017, and 2016, which was recorded in other income (expense), net. Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard & Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. We do not consider these investments to be other-than-temporarily impaired on December 31, 2018. On December 31, 2018 the majority of our investments with unrealized losses that were not deemed to be other-than-temporarily impaired were in a continuous unrealized loss position for less than twelve months, and the losses were not material.
Securities in a Continuous Unrealized Loss Position
| Number of Investments | Fair Value
Corporate and Asset-Backed | 75 | $ | 34 |
Foreign government | 0 | — |
United States Agency | 8 | 10 |
United States Treasury | 17 | 19 |
Certificate of Deposit | 15 | 7 |
Total | 115 | $ | 70 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration